KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Charles River Laboratories International (CRL) Receivables - Net (2016 - 2025)

Charles River Laboratories International has reported Receivables - Net over the past 17 years, most recently at $719.3 million for Q4 2025.

  • Quarterly results put Receivables - Net at $719.3 million for Q4 2025, changed 0.22% from a year ago — trailing twelve months through Dec 2025 was $719.3 million (changed 0.22% YoY), and the annual figure for FY2025 was $719.3 million, changed 0.22%.
  • Receivables - Net for Q4 2025 was $719.3 million at Charles River Laboratories International, down from $748.3 million in the prior quarter.
  • Over the last five years, Receivables - Net for CRL hit a ceiling of $818.7 million in Q3 2023 and a floor of $610.6 million in Q1 2021.
  • Median Receivables - Net over the past 5 years was $754.9 million (2022), compared with a mean of $740.8 million.
  • Biggest five-year swings in Receivables - Net: grew 22.35% in 2021 and later decreased 10.57% in 2024.
  • Charles River Laboratories International's Receivables - Net stood at $650.1 million in 2021, then increased by 15.74% to $752.4 million in 2022, then increased by 7.14% to $806.1 million in 2023, then decreased by 10.57% to $720.9 million in 2024, then fell by 0.22% to $719.3 million in 2025.
  • The last three reported values for Receivables - Net were $719.3 million (Q4 2025), $748.3 million (Q3 2025), and $780.4 million (Q2 2025) per Business Quant data.